Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study

Science Translational Medicine ◽

10.1126/scitranslmed.3010563 ◽

2015 ◽

Vol 7 (269) ◽

pp. 269ra2-269ra2 ◽

Author(s):

M. T. Schweizer ◽

E. S. Antonarakis ◽

H. Wang ◽

A. S. Ajiboye ◽

A. Spitz ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Castration Resistant Prostate Cancer ◽

Androgen Therapy ◽

Castration Resistant ◽

Pilot Clinical Study ◽

Asymptomatic Men

Download Full-text

Re: Effect of Bipolar Androgen Therapy for Asymptomatic Men with Castration-resistant Prostate Cancer: Results from a Pilot Clinical Study

European Urology ◽

10.1016/j.eururo.2015.05.028 ◽

2015 ◽

Vol 68 (3) ◽

pp. 538-539 ◽

Author(s):

Nathan Wilken ◽

Jason M. Scovell ◽

Ranjith Ramasamy

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Castration Resistant Prostate Cancer ◽

Androgen Therapy ◽

Castration Resistant ◽

Pilot Clinical Study ◽

Asymptomatic Men

Download Full-text

MP41-11 A PILOT CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF DOCETAXEL WITH RIBAVIRIN IN PATIENTS WITH PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER TARGETING STEM-CELL RELATED GENE NETWORK.

The Journal of Urology ◽

10.1016/j.juro.2017.02.1279 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Takeo Kosaka ◽

Takahiro Maeda ◽

Hirohiko Nagata ◽

Shunsuke Yoshimine ◽

Hiroshi Hongo ◽

...

Keyword(s):

Prostate Cancer ◽

Stem Cell ◽

Clinical Study ◽

Gene Network ◽

Cancer Targeting ◽

Efficacy And Safety ◽

Castration Resistant Prostate Cancer ◽

Related Gene ◽

Castration Resistant ◽

Pilot Clinical Study

Download Full-text

Molecular and Clinical Characterization of Patients with Metastatic Castration Resistant Prostate Cancer Achieving Deep Responses to Bipolar Androgen Therapy

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2021.08.001 ◽

2021 ◽

Author(s):

Mark C. Markowski ◽

Sushant Kachhap ◽

Angelo M. De Marzo ◽

Laura A. Sena ◽

Jun Luo ◽

...

Keyword(s):

Prostate Cancer ◽

Castration Resistant Prostate Cancer ◽

Androgen Therapy ◽

Castration Resistant

Download Full-text

Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

The Prostate ◽

10.1002/pros.23955 ◽

2020 ◽

Vol 80 (5) ◽

pp. 407-411

Author(s):

Mark C. Markowski ◽

Eugene Shenderov ◽

Mario A. Eisenberger ◽

Sushant Kachhap ◽

Drew M. Pardoll ◽

...

Keyword(s):

Prostate Cancer ◽

Immune Checkpoint ◽

Immune Checkpoint Blockade ◽

Checkpoint Blockade ◽

Castration Resistant Prostate Cancer ◽

Androgen Therapy ◽

Castration Resistant ◽

Extreme Responses

Download Full-text

Faculty Opinions recommendation of Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732320563.793553396 ◽

2018 ◽

Author(s):

Michael Glode

Keyword(s):

Prostate Cancer ◽

Phase 2 ◽

Castration Resistant Prostate Cancer ◽

Androgen Therapy ◽

Castration Resistant ◽

Open Label Phase

Download Full-text

Abstract 1114: Combining anti-androgen therapy and PARP inhibition results in synergistic cytotoxicity of metastatic castration-resistant prostate cancer (mCRPC) cells

10.1158/1538-7445.am2017-1114 ◽

2017 ◽

Author(s):

Sahithi Pamarthy ◽

Vinay Sagar ◽

Rajita J. Vatapalli ◽

Zachary Reinstein ◽

Muhammad Zayd Ansari ◽

...

Keyword(s):

Prostate Cancer ◽

Parp Inhibition ◽

Castration Resistant Prostate Cancer ◽

Androgen Therapy ◽

Castration Resistant ◽

Synergistic Cytotoxicity

Download Full-text

649P Abiraterone acetate in men with metastatic castration-resistant prostate cancer and no prior chemotherapy: A double-arm, multiple-centre, phase III clinical study

Annals of Oncology ◽

10.1016/j.annonc.2020.08.908 ◽

2020 ◽

Vol 31 ◽

pp. S530

Author(s):

Z. Hu ◽

Z. Ye ◽

H. Zeng ◽

Y. Huang ◽

D. Ye ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Abiraterone Acetate ◽

Phase Iii ◽

Castration Resistant Prostate Cancer ◽

Prior Chemotherapy ◽

Castration Resistant

Download Full-text

CLINICAL STUDY OF MDV3100 IN PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER (CRPC)

The Journal of Urology ◽

10.1016/s0022-5347(09)60655-8 ◽

2009 ◽

Vol 181 (4S) ◽

pp. 230-230 ◽

Author(s):

Howard I Scher ◽

Tomasz Beer ◽

Celestia Higano ◽

Eleni Efstathiou ◽

Aseem Anand ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

PD32-05 PHASE I CLINICAL STUDY ON THE COMBINATION THERAPY OF CHP-NY-ESO-1 CANCER VACCINE AND MIS416 FOR THE TREATMENT OF PATIENTS WITH NY-ESO-1 EXPRESSING REFRACTORY UROTHELIAL CANCER OR CASTRATION-RESISTANT PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.681 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Takeshi Sasaki ◽

Mikiya Ishihara ◽

Hideki Kanda ◽

Yasuhide Hori ◽

Norihito Soga ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Combination Therapy ◽

Phase I ◽

Cancer Vaccine ◽

Urothelial Cancer ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A Phase I Clinical Study of High Dose Ketoconazole Plus Weekly Docetaxel for Metastatic Castration Resistant Prostate Cancer

The Journal of Urology ◽

10.1016/j.juro.2010.02.020 ◽

2010 ◽

Vol 183 (6) ◽

pp. 2219-2226 ◽

Author(s):

William D. Figg ◽

Sukyung Woo ◽

Wenhui Zhu ◽

Xiaohong Chen ◽

A. Seun Ajiboye ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Study ◽

Phase I ◽

High Dose ◽

Castration Resistant Prostate Cancer ◽

Weekly Docetaxel ◽

Castration Resistant

Download Full-text